Table 2: Test for association results between patient demographics (age, gender) and clinical profile (duration, hypertension, lipid therapy, BMI) with glycaemic control.

Variable Good Glycaemic Control
(HbA1c < 7%)		 Poor Glycaemic Control
(HbA1c ≥ 7%)		 P-value
Age, years
Mean (SD)		 54.9 (8.4) 55.1 (9.5) 0.406
Gender
Males, n (%)
Females, n (%)
Total, n (%)		 31 (56.4)
45 (35.4)
76 (41.8)		 24 (43.6)
82 (64.6)
106 (58.2)		 0.007
Duration, years
< 5 years, n (%)
5-9 years, n (%)
10+ years, n (%)		 34 (54.8)
29 (47.5)
13 (22.0)		 28 (45.2)
32 (52.5)
46 (78.0)		 0.001
Blood pressure
Non-hypertensive, n (%)
Hypertensive, n (%)		 21 (53.9)
55 (38.5)		 18 (46.1)
88 (61.5)		 0.062
Lipid therapy, n (%)
No
Yes		 23 (37.7)
53 (43.8)		 38 (62.3)
68 (56.2)		 0.266
BMI, kg/m2 Normal weight, n (%)
Overweight, n (%)
Obese, n (%)		 27 (42.2)
31 (38.3)
18 (48.7)		 37 (57.8)
50 (61.7)
19 (51.3)		 0.561